Price
Target price
€1.94
€1.94
-3.050%
-0.0608
-3.050%
€18.11
13.06.25 / Tradegate
WKN: A2DT49 / Symbol: IOVA / Name: Iovance Biotherapeutics / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Iovance Biotherapeutics Inc. Stock
Heavy losses for Iovance Biotherapeutics Inc. today as the stock fell by -€0.061 (-3.050%).
With 16 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 18 € there is potential for a 826.02% increase which would mean more than doubling the current price of 1.94 € for Iovance Biotherapeutics Inc..
So far the community has only identified positive things for Iovance Biotherapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Iovance Biotherapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Iovance Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | -3.050% | 8.314% | 21.868% | -75.162% | -71.853% | -73.633% | -92.589% |
| Ironwood Pharmaceuticals | -10.320% | 14.837% | -7.377% | -89.820% | -86.548% | -94.909% | -93.025% |
| Arrowhead Pharmaceuticals Inc. | -2.640% | -7.564% | -0.220% | -44.793% | -26.331% | -49.853% | -53.146% |
| Novocure Ltd | 4.200% | 9.318% | -3.023% | -21.596% | -46.016% | -73.835% | -72.285% |
Comments
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $16.00 to $8.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Mizuho from $30.00 to $10.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Barclays PLC from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
